title: Synaptic activity and nuclear calcium signaling protect hippocampal neurons from death signal-associated nuclear translocation of FoxO3a induced by extrasynaptic N-methyl-D-aspartate receptors.
abstract: Synaptic activity and the generation of nuclear calcium signals promote neuronal survival through a transcription-dependent process that is not fully understood. Here we show that one mechanism of activity-induced acquired neuroprotection involves the Forkhead transcription factor, FoxO3a, which is known to induce genomic death responses upon translocation from the cytosol to the nucleus. Depletion of endogenous FoxO3a using RNA interference renders hippocampal neurons more resistant to excitotoxic cell death. Using a FoxO3a-green fluorescent protein (GFP) fusion protein to monitor in real time the localization of FoxO3a in hippocampal neurons, we found that several cell death inducing stimuli, including the stimulation of extrasynaptic N-methyl-D-aspartate receptors, growth factor withdrawal, and oxygen-glucose deprivation, caused a swift translocation of FoxO3a-GFP from the cytosol to the cell nucleus. This translocation was inhibited in hippocampal neurons that had undergone prolonged periods of synaptic activity before exposure to cell death-inducing conditions. The activity-dependent protection from death signal-induced FoxO3a-GFP nuclear translocation required synaptic N-methyl-D-aspartate receptor activation and was dependent on nuclear calcium signaling and calcium/calmodulin-dependent protein kinase IV. The modulation of nucleo-cytoplasmic shuttling of FoxO3a may represent one mechanism through which nuclear calcium-induced genomic responses affect cell death processes.
authors.affiliation: Department of Neurobiology, Interdisciplinary Center for Neurosciences IZN, University of Heidelberg, 69120 Heidelberg, Germany.
authors.forename: Oliver
authors.initials: O
authors.lastname: Dick
authors.forename: Hilmar
authors.initials: H
authors.lastname: Bading
mesh_terms: D021581:Active Transport, Cell Nucleus; D000818:Animals; D002118:Calcium / Q000378:metabolism*; D020013:Calcium Signaling; D054734:Calcium-Calmodulin-Dependent Protein Kinase Type 4 / Q000378:metabolism; D002467:Cell Nucleus / Q000378:metabolism*; D000071316:Forkhead Box Protein O3; D051858:Forkhead Transcription Factors / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism; D049452:Green Fluorescent Proteins / Q000378:metabolism; D006624:Hippocampus / Q000378:metabolism*; D019636:Neurodegenerative Diseases / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism*; D009435:Synaptic Transmission
chemical_list: C499517:FOXO3 protein, human; D000071316:Forkhead Box Protein O3; D051858:Forkhead Transcription Factors; D016194:Receptors, N-Methyl-D-Aspartate; D049452:Green Fluorescent Proteins; D054734:Calcium-Calmodulin-Dependent Protein Kinase Type 4; D005947:Glucose; D002118:Calcium
references.citation: Biochem J. 2009 Mar 15;418(3):475-89
references.pmid: 19228121
references.citation: Mol Cell. 2004 May 21;14(4):416-8
references.pmid: 15149589
references.citation: Neurosci Lett. 2006 May 1;398(1-2):39-43
references.pmid: 16423457
references.citation: Sci STKE. 2003 Mar 04;2003(172):RE5
references.pmid: 12621150
references.citation: J Cell Biol. 2002 Feb 4;156(3):531-42
references.pmid: 11815629
references.citation: J Biol Chem. 2005 May 27;280(21):20530-8
references.pmid: 15769749
references.citation: J Neurosci. 2005 Apr 27;25(17):4279-87
references.pmid: 15858054
references.citation: EMBO J. 2004 Dec 8;23(24):4802-12
references.pmid: 15538382
references.citation: Science. 1991 Aug 23;253(5022):912-4
references.pmid: 1715095
references.citation: Nat Neurosci. 2002 May;5(5):405-14
references.pmid: 11953750
references.citation: Mol Cell Neurosci. 2007 Sep;36(1):13-26
references.pmid: 17651987
references.citation: Neuron. 2007 Feb 15;53(4):549-62
references.pmid: 17296556
references.citation: J Hypertens. 2005 Jul;23(7):1285-309
references.pmid: 15942449
references.citation: J Biol Chem. 1994 Jun 3;269(22):15520-7
references.pmid: 8195196
references.citation: Nature. 1997 Jan 16;385(6613):260-5
references.pmid: 9000075
references.citation: Mol Biol Cell. 2008 May;19(5):2014-25
references.pmid: 18287535
references.citation: Trends Biochem Sci. 2002 Jul;27(7):352-60
references.pmid: 12114024
references.citation: Oncogene. 2008 Apr 7;27(16):2276-88
references.pmid: 18391970
references.citation: Cell. 2004 May 14;117(4):421-6
references.pmid: 15137936
references.citation: Mol Biol Cell. 2005 Aug;16(8):3705-18
references.pmid: 15930121
references.citation: Cell Signal. 2002 Aug;14(8):649-54
references.pmid: 12020764
references.citation: Cell. 1999 Mar 19;96(6):857-68
references.pmid: 10102273
references.citation: Science. 1993 Apr 9;260(5105):181-6
references.pmid: 8097060
references.citation: Cancer Cell. 2003 Dec;4(6):463-76
references.pmid: 14706338
references.citation: Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):14873-8
references.pmid: 18815370
references.citation: Annu Rev Pharmacol Toxicol. 2001;41:471-505
references.pmid: 11264466
references.citation: Channels (Austin). 2009 Jul-Aug;3(4):233-8
references.pmid: 19690465
references.citation: J Neurosci. 2004 Dec 1;24(48):10858-67
references.pmid: 15574736
references.citation: J Neurosci. 2005 Feb 2;25(5):1137-48
references.pmid: 15689550
references.citation: Mol Endocrinol. 1997 Jun;11(6):725-37
references.pmid: 9171236
references.citation: J Cell Sci. 2007 Aug 1;120(Pt 15):2479-87
references.pmid: 17646672
references.citation: Recent Prog Horm Res. 1997;52:389-406; discussion 406-7
references.pmid: 9238860
references.citation: Cell Cycle. 2005 Jul;4(7):908-13
references.pmid: 15917664
references.citation: Oncogene. 2005 Nov 14;24(50):7410-25
references.pmid: 16288288
references.citation: Nat Rev Drug Discov. 2007 May;6(5):391-403
references.pmid: 17473844
references.citation: Arch Biochem Biophys. 2002 Jul 15;403(2):292-8
references.pmid: 12139979
references.citation: J Clin Invest. 2005 Sep;115(9):2382-92
references.pmid: 16100571
references.citation: J Cell Biol. 2005 Jul 18;170(2):295-304
references.pmid: 16009721
references.citation: Nat Neurosci. 2001 Mar;4(3):261-7
references.pmid: 11224542
references.citation: J Leukoc Biol. 2003 Jun;73(6):689-701
references.pmid: 12773501
references.citation: Br J Pharmacol. 2007 Apr;150(7):839-50
references.pmid: 17339844
references.citation: Neuron. 1999 Apr;22(4):789-98
references.pmid: 10230798
references.citation: J Neurosci. 2009 Apr 8;29(14):4420-9
references.pmid: 19357269
references.citation: BMC Neurosci. 2007 Jul 30;8:57
references.pmid: 17663775
references.citation: J Biol Chem. 2002 Dec 6;277(49):47928-37
references.pmid: 12351634
references.citation: J Physiol. 2005 Apr 1;564(Pt 1):3-19
references.pmid: 15618268
references.citation: BMC Neurosci. 2008 Jan 24;9:11
references.pmid: 18218077
references.citation: Mol Cell Biol. 1994 Sep;14(9):6107-16
references.pmid: 8065343
references.citation: Endocrinology. 1999 Jul;140(7):3140-6
references.pmid: 10385407
references.citation: Oncogene. 2009 Feb 5;28(5):721-33
references.pmid: 19029949
references.citation: Neuroscience. 1995 Feb;64(3):653-64
references.pmid: 7715778
references.citation: Trends Neurosci. 2003 Feb;26(2):81-9
references.pmid: 12536131
references.citation: Nat Rev Immunol. 2004 Nov;4(11):889-99
references.pmid: 15516968
references.citation: Antioxid Redox Signal. 2005 May-Jun;7(5-6):752-60
references.pmid: 15890021
references.citation: Science. 1998 Sep 4;281(5382):1505-9
references.pmid: 9727976
references.citation: BMC Neurosci. 2004 Nov 29;5:48
references.pmid: 15569384
references.citation: J Immunol. 2002 May 15;168(10):5024-31
references.pmid: 11994454
references.citation: PLoS Genet. 2009 Aug;5(8):e1000604
references.pmid: 19680447
references.citation: J Biol Chem. 2000 May 5;275(18):13406-10
references.pmid: 10747847
references.citation: J Biol Chem. 1995 Dec 22;270(51):30245-8
references.pmid: 8530438
references.citation: Exp Gerontol. 2006 Oct;41(10):928-34
references.pmid: 16839734